AI breast imaging firm Densitas is launching its intelliRisk platform, which helps manage high-risk breast cancer patients.
IntelliRisk aims to help healthcare providers identify, assess, and manage high-risk patients by incorporating established guidelines and recommendations to support clinical decision-making tailored to individual women. Available as a standalone web application or integrated with electronic health record (EHR) systems, intelliRisk provides personalized screening guidance and patient management workflows aligned with best practices, Densitas said.
